Cantor Fitzgerald maintains Camtek stock rating on packaging outlook By Investing.com

Cantor Fitzgerald kept a Neutral rating on Camtek with a $160 price target, well below the $205.54 current price, citing risk that 2026 growth may fall short of peer-set expectations. The firm's current forecast is 13% fiscal 2026 revenue growth and EPS of $3.82, versus the need for at least 25% year-over-year growth in advanced packaging to stay competitive. Management may guide to a more conservative high-teens to low-20% growth rate, even as Camtek benefits from strong AI-related orders and the Visual Layer acquisition.

Analysis

CAMT is in a classic expectation-vs-execution trap: the business can still be structurally improving while the stock de-rates if the market concludes that second-half acceleration is not enough to justify the multiple. The key second-order effect is that advanced packaging is becoming a quasi-benchmark segment; once peers publicly set a >50% growth bar for 2026, any supplier exposed to the same end-market is implicitly judged on relative share gains, not just absolute growth. That makes “good” results insufficient if they come with cautious guidance — the equity can sell off even on improving fundamentals.

The setup also argues for a near-term valuation reset rather than a fundamental collapse. When a stock trades at an earnings multiple that already prices in multiple years of outperformance, the market tends to punish any guide that implies linear rather than accelerating growth. If management frames 2H as normalizing instead of inflecting, the multiple can compress faster than estimates move, which is the real risk here over the next 1-2 earnings cycles.

A subtle contrarian angle is that the market may be overestimating how much advanced packaging exposure can be directly translated into near-term revenue, while underestimating the optionality from the AI-leaning order book and strategic acquisition. That optionality matters more in 2027 than in 2026, so the stock could be dead money or lower in the next few months even if the longer-term thesis remains intact. The right way to express this is not to bet against the business, but against the gap between narrative and the cadence of realized revenue.

For MS, the implication is mostly positioning-related rather than fundamental: if the sell-side tone around CAMT turns cautious, it reinforces a broader semi-cap valuation reset in the high-growth metrology/inspection bucket. That can create relative-value opportunities in higher-quality names with less need for perfect second-half execution.

Key Decisions for Investors

• Short CAMT into strength ahead of guidance, ideally on any pre-earnings rally above the current range; target a 10-15% drawdown if management frames 2026 growth in high-teens/low-20s rather than the market’s implied step-up.
• Buy CAMT put spreads for the next earnings window to capture multiple compression risk with defined downside; structure for a 2:1 or better payoff if the stock rerates toward the next consensus anchor.
• Pair trade: short CAMT / long a higher-quality semi capital equipment or inspection peer with less guide risk, to isolate valuation compression from sector beta over the next 1-3 months.
• If already long CAMT, trim into any post-earnings strength and re-enter only after 2H order visibility improves; use a trailing stop around the last major support zone to avoid multiple compression from a cautious guide.
• For tactical traders, consider a call-spread sale against CAMT if implied vol spikes into the event; the thesis is that guidance risk is asymmetric to the downside while upside is capped by already-stretched expectations.